Five cases of new‐onset pemphigus following vaccinations against coronavirus disease 2019

Pemphigus is a group of blistering disorders characterized by the formation of intraepithelial blisters in skin and mucous membranes induced by the binding of circulating autoantibodies to intercellular adhesion molecules. The pathogenesis is complex and not fully understood; however, genetic predis...

Descripción completa

Detalles Bibliográficos
Autores principales: Corrá, Alberto, Barei, Francesca, Genovese, Giovanni, Zussino, Martina, Spigariolo, Cristina B., Mariotti, Elena B., Quintarelli, Lavinia, Verdelli, Alice, Caproni, Marzia, Marzano, Angelo V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Concise Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538601/
https://www.ncbi.nlm.nih.gov/pubmed/35975548
http://dx.doi.org/10.1111/1346-8138.16554
Descripción
Sumario:Pemphigus is a group of blistering disorders characterized by the formation of intraepithelial blisters in skin and mucous membranes induced by the binding of circulating autoantibodies to intercellular adhesion molecules. The pathogenesis is complex and not fully understood; however, genetic predisposition and various triggers are widely accepted as key factors in pemphigus development. A few cases of new‐onset pemphigus following coronavirus disease 2019 (COVID‐19) vaccination have already been published. The present paper reports a total of two cases of pemphigus foliaceous and three cases of pemphigus vulgaris that occurred following vaccinations against COVID‐19, with anamnestic, clinical, and diagnostic data collection suggesting assumptions over a possible causal correlation.

Ejemplares similares